A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers

NCT02452268 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

83

Enrollment

INDUSTRY

Sponsor class

Stopped business decision

Conditions

Metastatic and Advanced Solid Tumors

Interventions

DRUG: NIZ985
DRUG: PDR001

Sponsor

Novartis Pharmaceuticals